Free IC&RC ADC Exam Flashcards

Views substance use disorder as a chronic, relapsing brain condition rather than a moral failing or simple lack of willpower. Repeated use alters reward, motivation, and impulse-control circuits, which supports ongoing treatment and relapse-informed care instead of one-time punishment or willpower-only expectations.

Addictive substances trigger dopamine surges along the mesolimbic pathway (ventral tegmental area to nucleus accumbens), reinforcing drug-seeking behavior beyond natural rewards like food or social connection. Repeated surges blunt the system over time, contributing to tolerance and reduced pleasure from everyday activities during early recovery.

Tolerance means needing more of a substance for the same effect; physical dependence means a withdrawal syndrome appears on stopping or reducing use. Both can occur with appropriate long-term medical treatment (for example opioid pain therapy) without addiction, which adds compulsive use despite harm and loss of control over use.

Genetics contribute substantially to risk, and environment compounds it: adverse childhood experiences, family history of addiction, early age of first use, trauma, peer influence, and co-occurring mental illness all raise risk. No single factor determines outcome, so counselors assess the combination relevant to the individual client.

Alcohol, benzodiazepines, and barbiturates act on the GABA-A receptor system and show cross-tolerance, so heavy use of one raises tolerance to the others. This is why benzodiazepines are the first-line medication for managing alcohol withdrawal, and why a long-acting drug from this group can substitute for a shorter-acting one during a supervised taper.

Classic opioid overdose signs are pinpoint pupils, slowed or stopped breathing, and decreased consciousness. Naloxone is an opioid antagonist that can rapidly reverse an overdose but can also precipitate acute withdrawal, and its effect can wear off before the opioid's does, so emergency care and monitoring are still needed after a dose.

Early alcohol withdrawal (tremor, anxiety, elevated vital signs) can begin within hours of the last drink; withdrawal seizures typically cluster in the first day or two, and delirium tremens is a later, life-threatening complication. Withdrawal history and medical status, not drinking amount alone, determine whether medically supervised withdrawal is needed.

Stimulant (cocaine, methamphetamine) intoxication causes euphoria, rapid heart rate, elevated blood pressure, and agitation; withdrawal causes a 'crash' of fatigue, low mood, increased appetite, and intense cravings rather than the dangerous autonomic instability seen in alcohol or sedative withdrawal. Screening for suicide risk during the crash phase matters.

Abrupt discontinuation after regular benzodiazepine use can cause rebound anxiety, tremor, and withdrawal seizures, a danger similar to alcohol withdrawal. A gradual, medically supervised taper, not abrupt cessation, is the standard approach to reduce seizure and complication risk.

Opioids taken with benzodiazepines, alcohol, or other CNS depressants add to each other's sedating and breathing-suppressing effects, so a dose that is survivable alone can be fatal in combination. FDA boxed warnings flag the opioid-benzodiazepine combination, which is why counselors screen for every substance a client uses, not just the primary drug.

Many people with a substance use disorder also have a co-occurring mental health condition, such as depression, anxiety, or PTSD. Integrated treatment that addresses both conditions together, rather than treating one and deferring the other, produces better outcomes than sequential or siloed care.

Chronic substance use raises the risk of conditions tied to the substance and how it is used: cirrhosis from heavy drinking, lung and airway damage from smoked substances such as tobacco, cannabis, or crack cocaine, and HIV, hepatitis C, and other sexually transmitted or bloodborne infections from injection or high-risk sexual behavior. Screening and medical referral are part of a comprehensive assessment, not an afterthought.

CNS depressants (alcohol, benzodiazepines, barbiturates) slow brain activity and share withdrawal risk; opioids relieve pain and cause euphoria with overdose risk from slowed breathing; stimulants increase alertness with cardiovascular risk; hallucinogens alter perception with low physical dependence potential. Classification guides expected intoxication, withdrawal, and safety concerns.

CAGE-AID adapts the four-item CAGE alcohol screen (Cut down, Annoyed, Guilty, Eye-opener) to also ask about drug use. Two or more 'yes' answers is a widely used threshold suggesting further assessment is needed; CAGE-AID is a brief screen, not a diagnostic tool.

The ASI is a semi-structured interview that rates problem severity across seven domains: medical, employment/support, drug use, alcohol use, legal, family/social, and psychiatric. It produces severity ratings per domain to guide treatment planning rather than a single pass/fail score.

OARS are the core micro-skills of motivational interviewing: Open-ended questions, Affirmations, Reflective listening, and Summaries. Counselors use OARS to evoke a client's own motivation for change rather than arguing for change or persuading directly.

Prochaska and DiClemente's model describes precontemplation (not considering change), contemplation (weighing pros and cons), preparation (planning to act soon), action (actively changing), and maintenance (sustaining change). A lapse can return a client to an earlier stage, so interventions should match the client's current stage rather than assume everyone is ready for action.

DSM-5-TR uses a single substance use disorder diagnosis instead of the older abuse/dependence split. For most substances it lists 11 criteria (impaired control, social impairment, risky use, pharmacological); at least 2 within 12 months are required, and severity is mild (2-3), moderate (4-5), or severe (6 or more). Tolerance or withdrawal from a medication taken as prescribed under medical supervision does not count.

A biopsychosocial assessment gathers medical history, family and social relationships, employment and legal status, and substance use patterns, often supplemented with collateral sources such as family or prior providers when the client consents. It identifies immediate safety needs and informs the appropriate level of care, not just a diagnosis.

Dimension 1 of the ASAM Criteria Fourth Edition looks at current intoxication, withdrawal risk, and the client's need for addiction medications such as buprenorphine or methadone. The Fourth Edition folds withdrawal management into the main levels of care instead of separate withdrawal-only levels, so high withdrawal risk points to a medically managed level (1.7, 2.7, 3.7, or 4) that can provide that care.

New in the ASAM Criteria Fourth Edition, Dimension 6 takes the place of the Third Edition's separate 'Readiness to Change' dimension, whose considerations are now spread across all dimensions. It covers client preferences, barriers to care including social determinants of health, and need for motivational enhancement. Dimensions 1-5 produce the level-of-care recommendation; Dimension 6 guides shared decision-making about which level the client is willing and able to engage in.

Initial urine drug screens use immunoassay methods that are fast but prone to false positives and cross-reactivity; a presumptive positive should be confirmed with a more specific method, such as gas chromatography-mass spectrometry, before major clinical or legal decisions are made. Detection windows vary widely by substance, dose, and individual metabolism.

The ASAM Criteria Fourth Edition adult continuum has four broad levels: Level 1 outpatient (including the new 1.0 long-term remission monitoring), Level 2 intensive and high-intensity outpatient, Level 3 residential, and Level 4 medically managed inpatient, with decimals marking gradations within each. Early intervention (Level 0.5 in the Third Edition) is no longer one of these levels. Placement follows assessed risk in Dimensions 1-5, not a general impression of severity.

Rapport forms through consistent empathy, respect, and attention to the client's goals rather than the counselor's own agenda. A strong working alliance, meaning agreement on goals, tasks, and a trusting bond, is one of the most consistent predictors of engagement and outcome across counseling approaches.

De-escalation prioritizes safety first: speak calmly, give the person space, avoid confrontational body language, and validate feelings without agreeing to unsafe demands. The goal is to reduce arousal and risk before problem-solving, not to resolve the underlying issue during the crisis itself.

A warm handoff directly connects a client to the next provider, for example through a phone call or joint appointment, instead of just handing over a phone number. It reduces the drop-off between referral and engagement, which matters most when a client is ambivalent or in crisis.

Goals describe the broad desired outcome, such as sustained recovery; objectives break the goal into specific, measurable, time-limited steps, such as attending group sessions a set number of times per week. Plans are updated as the client's needs, strengths, and progress change, not written once and left static.

Groups commonly move through forming (orientation), storming (conflict and testing), norming (cohesion and shared norms), and performing (productive work), with adjourning as the group ends. A counselor's role shifts across stages, for example managing conflict directly during storming rather than avoiding it.

Ambivalence about change is expected, not a sign of a resistant client. Counselors listen for and reinforce 'change talk' (statements favoring change) while responding to 'sustain talk' with reflection rather than argument, since direct persuasion tends to increase a client's defense of the status quo.

Marlatt's relapse prevention model identifies high-risk situations, such as negative emotions, interpersonal conflict, or social pressure, as common relapse triggers. Treatment builds specific coping skills and rehearses responses for the client's identified triggers rather than relying on willpower alone.

The abstinence violation effect is the guilt and hopelessness that can follow a single lapse, which can itself drive a full relapse if the client interprets the lapse as total failure. Counselors reframe a lapse as a specific, understandable event to learn from, not proof that recovery has failed.

Trauma-informed care emphasizes safety, trustworthiness and transparency, peer support, collaboration, empowerment and choice, and cultural responsiveness throughout services. It assumes trauma history is common and avoids practices that could re-traumatize a client, such as unnecessary coercion or confrontation.

Vicarious trauma is the cumulative emotional effect of repeatedly hearing clients' traumatic experiences, which can mirror trauma symptoms in the counselor over time. Supervision, peer consultation, caseload management, and deliberate self-care are standard safeguards, not optional extras.

A complete discharge plan addresses continuing care: a specific aftercare appointment or program, a written relapse and recovery plan, referrals for any unresolved medical or mental health needs, and connections to recovery supports. Discharge without a concrete next step raises relapse risk.

Recovery pathways include 12-step mutual-aid groups, SMART Recovery and other secular or cognitive-behavioral mutual aid, medication-assisted treatment, faith-based programs, and harm reduction approaches. No single pathway fits every client, so counselors support the client's chosen combination rather than insisting on one model.

Methadone is a full opioid agonist; outpatient methadone for opioid use disorder must come from a certified opioid treatment program. SAMHSA's 2024 Part 8 rule replaced the old time-in-treatment take-home schedule with clinical judgment, allowing up to 28 days of take-homes from day 31 of treatment. Buprenorphine is a partial agonist with a ceiling on respiratory depression; since the Consolidated Appropriations Act, 2023 ended the X-waiver, any practitioner with a standard DEA registration covering Schedule III can prescribe it, subject to state law, with no federal patient cap.

Naltrexone is an opioid antagonist available as a daily oral tablet or a monthly extended-release injection. Starting it, especially the extended-release form, while opioids remain in the system can precipitate severe withdrawal, so the FDA label recommends a minimum of 7 to 10 opioid-free days (longer after methadone or buprenorphine) before the first dose.

During pregnancy, methadone or buprenorphine is recommended over medically supervised withdrawal, which carries high relapse rates, and abruptly stopping opioids can lead to complications such as preterm labor or miscarriage. Counselors coordinate with obstetric and pediatric providers and prepare families for newborn monitoring for neonatal withdrawal, which is an expected, treatable condition and not a reason to avoid the medication.

A dual relationship exists when a counselor has another significant role with a client, such as a business, family, or social relationship. Some overlap may be unavoidable in small or rural communities, but the counselor must recognize the risk to objectivity and client welfare, disclose it, and add safeguards such as supervision rather than assuming the relationship is automatically disqualifying or automatically fine.

Counselor self-disclosure is appropriate only when it serves the client's treatment goals, stays brief, and keeps the focus on the client rather than the counselor's own needs. Disclosure that shifts attention to the counselor, pressures the client, or edges toward a social relationship is a boundary concern, not a rapport-building tool.

Scope of practice is defined by the counselor's training, credential, and jurisdiction's rules, not by client need alone. When a client's needs fall outside that scope, such as a medication question or an unaddressed eating disorder, the counselor's responsibility is to recognize the limit and refer or consult rather than attempt to manage it independently.

Treatment documentation should be objective, timely, and specific to the service delivered, linking observations and interventions to the treatment plan. Records must also be stored securely, with access limited to authorized staff and retention or destruction following law and program policy (Part 2 programs need formal written security policies). Vague, judgmental, late, or poorly secured records weaken clinical continuity and the program's legal defensibility.

Under the 2024 Part 2 final rule, with compliance required by February 16, 2026, a single patient consent can authorize all future disclosures for treatment, payment, and health care operations rather than requiring a new consent for each recipient. Substance use disorder counseling notes still require their own separate consent.

Key exceptions to the consent requirement include a bona fide medical emergency, qualifying research, audit or evaluation, a qualified service organization agreement, a court order issued under the Part 2 Subpart E procedure (a subpoena alone is not enough), the initial report of suspected child abuse or neglect required by state law, and limited information about a crime on program premises or against program personnel.

Informed consent requires that the client understand the purpose of a service, its risks, benefits, and alternatives, and agree voluntarily without coercion. It also includes the right to ask questions, decline a specific intervention, and withdraw consent later; a signature alone does not establish informed consent if understanding was never confirmed.

A conflict of interest arises when a counselor's personal, financial, or other interest could influence professional judgment, such as referring a client to a program the counselor profits from without disclosure. Ethical practice requires identifying the conflict, disclosing it to relevant parties, and stepping back from the decision when needed.

Clinical supervision provides ongoing oversight of a counselor's casework and skill development, while consultation is a more informal exchange with a colleague about a specific case or ethical question. Both are expected professional safeguards, used proactively for complex or high-risk cases rather than only after a problem has already occurred.

Clients have a right to raise concerns about their care through a formal grievance process without retaliation or loss of services. Programs explain how to file a grievance, and the process lets the client take the complaint beyond the staff member involved and receive a documented response. Counselors respond without defensiveness and follow the written procedure rather than discouraging or informally burying the complaint.

Cultural humility is an ongoing process of self-reflection and openness to a client's cultural context, rather than a one-time training or a checklist of group traits. It requires counselors to recognize their own biases and the power difference in the relationship and adapt care accordingly, supporting diversity, inclusion, and equity in treatment access.

Clients generally retain rights to be treated with dignity, to receive information about their care, to confidentiality protections, to refuse a recommended treatment, and to file a grievance without losing access to services. Respecting these rights is a professional and ethical obligation throughout the counseling relationship, not just at intake.